SPHERA FUNDS MANAGEMENT LTD. - POINT BIOPHARMA GLOBAL INC ownership

POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 130 filers reported holding POINT BIOPHARMA GLOBAL INC in Q3 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.1%.

Quarter-by-quarter ownership
SPHERA FUNDS MANAGEMENT LTD. ownership history of POINT BIOPHARMA GLOBAL INC
ValueSharesWeighting
Q3 2023$6,354,122
-26.4%
952,6420.0%1.16%
-14.2%
Q2 2023$8,630,937
+24.6%
952,6420.0%1.35%
+16.5%
Q1 2023$6,925,707
-0.3%
952,6420.0%1.16%
-22.4%
Q4 2022$6,944,760
-14.7%
952,642
-9.5%
1.49%
+31.9%
Q3 2022$8,138,000
+145.2%
1,052,842
+77.7%
1.13%
+209.6%
Q4 2021$3,319,000
-41.6%
592,592
-19.8%
0.36%
-23.6%
Q3 2021$5,684,000739,1900.48%
Other shareholders
POINT BIOPHARMA GLOBAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
Fairmount Funds Management LLC 2,312,523$18,431,0004.36%
GREAT POINT PARTNERS LLC 2,060,000$16,418,0003.97%
RA Capital Management 9,003,018$71,754,0001.57%
JOHNSON & JOHNSON 1,000,000$7,970,0001.51%
BVF INC/IL 3,367,826$26,842,0001.07%
Boxer Capital, LLC 2,500,000$19,925,0001.02%
Sio Capital Management, LLC 377,684$3,010,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 3,014,408$24,025,0000.73%
SILVERARC CAPITAL MANAGEMENT, LLC 204,679$1,631,0000.68%
Atom Investors LP 60,103$479,0000.22%
View complete list of POINT BIOPHARMA GLOBAL INC shareholders